Twist Bioscience
TWST
236 hedge funds and large institutions have $3.96B invested in Twist Bioscience in 2021 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 83 increasing their positions, 74 reducing their positions, and 43 closing their positions.
113% more capital inflows, than outflows
Capital inflows: $577M | Capital outflows: $271M
12% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 74
4.53% more ownership
Funds ownership: 98.72% → 103.25% (+4.5%)
2% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 43
0% less funds holding
Funds holding: 237 → 236 (-1)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
46% less call options, than puts
Call options by funds: $8.03M | Put options by funds: $14.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAM
Ardevora Asset Management
London,
United Kingdom
|
+$71.8M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$42M |
| 3 |
BlackRock
New York
|
+$32.4M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$31.3M |
| 5 |
Millennium Management
New York
|
+$30.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$43.8M |
| 2 |
Casdin Capital
New York
|
-$33.9M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$27.9M |
| 4 |
ARK Investment Management
St. Petersburg,
Florida
|
-$18.4M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$17.4M |
TWST Hedge Fund Activity: Q4 2021 in Review
236 of the 6,524 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q4 2021, worth a combined $3.96B — down 24% from $5.2B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new TWST positions and 43 closed out — a net gain of 1 holder — while 83 added to existing stakes and 74 trimmed.
The largest buyer was Ardevora Asset Management, opening a new position worth an estimated $71.8M. The largest seller was Wells Fargo, cutting an estimated $43.8M.
- 236 institutional investors held Twist Bioscience (TWST) as of Q4 2021, down from 237 in Q3 2021.
- Funds reported $3.96B of Twist Bioscience stock for Q4 2021, down 24% quarter-over-quarter.
- 44 funds opened new Twist Bioscience positions in Q4 2021 and 43 closed out, a net change of +1 holder.
- The largest Twist Bioscience buyer in Q4 2021 was Ardevora Asset Management, an estimated $71.8M added.
- The largest Twist Bioscience seller in Q4 2021 was Wells Fargo, an estimated $43.8M sold.
Based on aggregated 13F filings for Q4 2021.